{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:49:15Z","timestamp":1791899355371,"version":"4.3.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) has unclear pathogenesis, but the molecules that feed its inflammatory state are known. Small interfering RNAs (siRNAs) are useful to identify molecular targets and evaluate the efficacy of specific drugs, and can themselves be used for therapeutic purposes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Sources of data<\/jats:title>\n                    <jats:p>A systematic search of different databases to March 2022 was performed to define the role of siRNAs in RA therapy. Twenty suitable studies were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas of agreement<\/jats:title>\n                    <jats:p>Small interfering RNAs can be useful in the study of inflammatory processes in RA, and identify possible therapeutic targets and drug therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas of controversy<\/jats:title>\n                    <jats:p>Many genes and cytokines participate in the inflammatory process of RA and can be regulated with siRNA. However, it is difficult to determine whether the responses to siRNAs and other drugs studied in human cells in vitro are similar to the responses in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Growing points<\/jats:title>\n                    <jats:p>Inflammatory processes can be affected by the gene dysregulation of siRNAs on inflammatory cytokines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas timely for developing research<\/jats:title>\n                    <jats:p>To date, it is not possible to determine whether the pharmacological response of siRNAs on cells in vitro would be similar to what takes place in vivo for the diseases studied so far.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bmb\/ldac012","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T07:06:57Z","timestamp":1650784017000},"page":"34-43","source":"Crossref","is-referenced-by-count":192,"title":["Small interfering RNAs in the management of human rheumatoid arthritis"],"prefix":"10.1093","volume":"142","author":[{"given":"Giuseppe","family":"Gargano","sequence":"first","affiliation":[{"name":"Department of Trauma and Orthopaedic Surgery, AOU San Giovanni di Dio e Ruggi D\u2019Aragona , Via San Leonardo 1, Salerno 84131 , Italy"},{"name":"Department of Medicine , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"},{"name":"University of Salerno , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Oliva","sequence":"additional","affiliation":[{"name":"Department of Trauma and Orthopaedic Surgery, AOU San Giovanni di Dio e Ruggi D\u2019Aragona , Via San Leonardo 1, Salerno 84131 , Italy"},{"name":"Department of Medicine , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"},{"name":"University of Salerno , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliviero","sequence":"additional","affiliation":[{"name":"Department of Trauma and Orthopaedic Surgery, AOU San Giovanni di Dio e Ruggi D\u2019Aragona , Via San Leonardo 1, Salerno 84131 , Italy"},{"name":"Department of Medicine , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"},{"name":"University of Salerno , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maffulli","sequence":"additional","affiliation":[{"name":"Department of Trauma and Orthopaedic Surgery, AOU San Giovanni di Dio e Ruggi D\u2019Aragona , Via San Leonardo 1, Salerno 84131 , Italy"},{"name":"Department of Medicine , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"},{"name":"University of Salerno , Surgery and Dentistry, , Via S. Allende, Baronissi SA 84081 , Italy"},{"name":"Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, Mile End Hospital , 275 Bancroft Road, London E1 4DG , UK"},{"name":"School of Pharmacy and Bioengineering, Keele University School of Medicine , Thornburrow Drive, Stoke on Trent, ST4 7QB , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"2022080412420706300_ref1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","article-title":"Early diagnosis and treatment of rheumatoid arthritis","volume":"45","author":"Littlejohn","year":"2018","journal-title":"Prim Care"},{"key":"2022080412420706300_ref2","first-page":"1245","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"84","author":"Wasserman","year":"2011","journal-title":"Am Fam Physician"},{"key":"2022080412420706300_ref3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/JSA.0b013e318224e44e","article-title":"A systematic review of the reverse shoulder replacement in rotator cuff arthropathy, rotator cuff tears, and rheumatoid arthritis","volume":"19","author":"Khan","year":"2011","journal-title":"Sports Med Arthrosc Rev"},{"key":"2022080412420706300_ref4","first-page":"103","article-title":"Genetics in orthopaedic practice","volume":"33","author":"Aicale","year":"2019","journal-title":"J Biol Regul Homeost Agent"},{"key":"2022080412420706300_ref5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/JSA.0000000000000192","article-title":"Cell therapies in Tendon, ligament, and musculoskeletal system repair","volume":"26","author":"Albornoz","year":"2018","journal-title":"Sports Med Arthrosc Rev"},{"key":"2022080412420706300_ref6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/bmb\/ldz015","article-title":"MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge","volume":"130","author":"Oliviero","year":"2019","journal-title":"Br Med Bull"},{"key":"2022080412420706300_ref7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/JSA.0000000000000187","article-title":"Making them commit: strategies to influence phenotypic differentiation in mesenchymal stem cells","volume":"26","author":"Giai Via","year":"2018","journal-title":"Sports Med Arthrosc Rev"},{"key":"2022080412420706300_ref8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/cells9051268","article-title":"Tendon and cytokine marker expression by human bone marrow mesenchymal stem cells in a hyaluronate\/poly-lactic-co-glycolic acid (PLGA)\/Fibrin three-dimensional (3D) scaffold","volume":"9","author":"Ciardulli","year":"2020","journal-title":"Cell"},{"key":"2022080412420706300_ref9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat Chem Biol"},{"key":"2022080412420706300_ref10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-biophys-083012-130404","article-title":"Molecular mechanisms of RNA interference","volume":"42","author":"Wilson","year":"2013","journal-title":"Annu Rev Biophys"},{"key":"2022080412420706300_ref11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/bmb\/ldaa040","article-title":"Small interfering RNAs in tendon homeostasis","volume":"138","author":"Gargano","year":"2021","journal-title":"Br Med Bull"},{"key":"2022080412420706300_ref12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14712598.2018.1492541","article-title":"How far have biological therapies come in regenerative sports medicine?","volume":"18","author":"Andia","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"2022080412420706300_ref13","doi-asserted-by":"crossref","first-page":"20031","DOI":"10.1038\/srep20031","article-title":"siRNAmod: a database of experimentally validated chemically modified siRNAs","volume":"6","author":"Dar","year":"2016","journal-title":"Sci Rep"},{"key":"2022080412420706300_ref14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-019-1954-3","article-title":"Rheumatoid arthritis synovial fibroblasts promote TREM-1 expression in monocytes via COX-2\/PGE2 pathway","volume":"21","author":"Peng","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022080412420706300_ref15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11033-020-06069-z","article-title":"Role of MDA5 in regulating CXCL10 expression induced by TLR3 signaling in human rheumatoid fibroblast-like synoviocytes","volume":"48","author":"Saruga","year":"2021","journal-title":"Mol Biol Rep"},{"key":"2022080412420706300_ref16","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar3811","article-title":"The Sp1 transcription factor is essential for the expression of gliostatin\/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes","volume":"14","author":"Ikuta","year":"2012","journal-title":"Arthr Res Ther"},{"key":"2022080412420706300_ref17","doi-asserted-by":"crossref","first-page":"8600","DOI":"10.1016\/j.biomaterials.2012.08.008","article-title":"The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis","volume":"33","author":"Park","year":"2012","journal-title":"Biomaterials"},{"key":"2022080412420706300_ref18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-016-2783-1","article-title":"Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression","volume":"420","author":"Li","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"2022080412420706300_ref19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2015-208736","article-title":"Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase\/p53 axis","volume":"75","author":"Municio","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022080412420706300_ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J Craniomaxillofac Surg"},{"key":"2022080412420706300_ref21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/rheumatology\/ker327","article-title":"Hypoxia differentially affects IL-1\u03b2-stimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1\u03b1-dependent manner","volume":"51","author":"Lee","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2022080412420706300_ref22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jcmm.13020","article-title":"Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"21","author":"Chen","year":"2017","journal-title":"J Cell Mol Med"},{"key":"2022080412420706300_ref23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gene.2016.07.053","article-title":"Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis","volume":"592","author":"Xu","year":"2016","journal-title":"Gene"},{"key":"2022080412420706300_ref24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.colsurfb.2017.04.023","article-title":"Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages","volume":"155","author":"Nogueira","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2022080412420706300_ref25","first-page":"2393","article-title":"An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome-protamine-DNA-siRNA complex with cell permeable peptides","volume":"42","author":"Wang","year":"2018","journal-title":"Int J Mol Med"},{"key":"2022080412420706300_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/6670464","article-title":"Knockdown of Nrf2 exacerbates TNF-\u03b1-induced proliferation and invasion of rheumatoid arthritis fibroblast-like synoviocytes through activating JNK pathway","volume":"2020","author":"Du","year":"2020","journal-title":"J Immunol Res"},{"key":"2022080412420706300_ref27","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/ptr.7130","article-title":"Geniposide downregulates the VEGF\/SphK1\/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro","volume":"35","author":"Wang","year":"2021","journal-title":"Phytother Res PTR"},{"key":"2022080412420706300_ref28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-020-02369-8","article-title":"Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"22","author":"Choi","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022080412420706300_ref29","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1038\/s41598-021-87199-7","article-title":"Eotaxin-1\/CCL11 is involved in cell migration in rheumatoid arthritis","volume":"11","author":"Wakabayashi","year":"2021","journal-title":"Sci Rep"},{"key":"2022080412420706300_ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5114\/ceji.2021.105243","article-title":"E2F2 stimulates CCR4 expression and activates synovial fibroblast-like cells in rheumatoid arthritis","volume":"46","author":"Xu","year":"2021","journal-title":"Cent-Eur J Immunol"},{"key":"2022080412420706300_ref31","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.3390\/ijms22137166","article-title":"B Cell adhesion to fibroblast-like synoviocytes is up-regulated by tumor necrosis factor-alpha via expression of human vascular cell adhesion molecule-1 mediated by B cell-activating factor","volume":"22","author":"Yoon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022080412420706300_ref32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13018-021-02451-0","article-title":"Angiotensin II upregulates RANKL\/NFATC1 expression in synovial cells from patients with rheumatoid arthritis through the ERK1\/2 and JNK pathways","volume":"16","author":"Zhao","year":"2021","journal-title":"J Orthop Surg"},{"key":"2022080412420706300_ref33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.intimp.2019.05.001","article-title":"Arsenic trioxide improves Treg and Th17 balance by modulating STAT3 in treatment-na\u00efve rheumatoid arthritis patients","volume":"73","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2022080412420706300_ref34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-019-1935-6","article-title":"A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients","volume":"21","author":"Ma","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022080412420706300_ref35","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I","article-title":"The role of the chondrocyte in osteoarthritis","volume":"43","author":"Goldring","year":"2000","journal-title":"Arthr Rheum"},{"key":"2022080412420706300_ref36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1019927616000","article-title":"Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts","volume":"238","author":"Nakao","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"2022080412420706300_ref37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jse.2011.10.020","article-title":"Metalloproteases and rotator cuff disease","volume":"21","author":"Del Buono","year":"2012","journal-title":"J Shoulder Elbow Surg"},{"key":"2022080412420706300_ref38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jbspin.2008.01.026","article-title":"Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy","volume":"75","author":"Wendling","year":"2008","journal-title":"Joint Bone Spine"},{"key":"2022080412420706300_ref39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1740-2557-3-5","article-title":"Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha","volume":"3","author":"Cordiali-Fei","year":"2006","journal-title":"J Autoimmune Dis"},{"key":"2022080412420706300_ref40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/scbi.2000.0365","article-title":"Proteases in invasion: matrix metalloproteinases","volume":"11","author":"Stetler-Stevenson","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"2022080412420706300_ref41","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"2022080412420706300_ref42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front Biosci J Virtual Libr"},{"key":"2022080412420706300_ref43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/ar401","article-title":"Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors","volume":"4","author":"Vincenti","year":"2002","journal-title":"Arthr Res"},{"key":"2022080412420706300_ref44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/1529-0131(199809)41:9<1639::AID-ART15>3.0.CO;2-0","article-title":"Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR\/ORT mouse model of osteoarthritis","volume":"41","author":"Brewster","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2022080412420706300_ref45","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1302\/0301-620X.80B5.0800907","article-title":"Dupuytren\u2019s disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor","volume":"80","author":"Hutchinson","year":"1998","journal-title":"J Bone Joint Surg Br"},{"key":"2022080412420706300_ref46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1749-6632.1999.tb07688.x","article-title":"Preclinical and clinical studies of MMP inhibitors in cancer","volume":"878","author":"Drummond","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"2022080412420706300_ref47","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1\u03b2 and TNF\u03b1-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"23","author":"Mori","year":"2011","journal-title":"Int Immunol"},{"key":"2022080412420706300_ref48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/039463200902200218","article-title":"The safety of anti-TNF agents in the elderly","volume":"22","author":"Migliore","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2022080412420706300_ref49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.joca.2011.12.002","article-title":"A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E\u2082 and matrix metalloproteinases synthesis in interleukin-1\u03b2-stimulated osteoblasts","volume":"20","author":"Pecchi","year":"2012","journal-title":"Osteoarthr Cartil"},{"key":"2022080412420706300_ref50","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/jcp.22981","article-title":"Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts","volume":"227","author":"Ongaro","year":"2012","journal-title":"J Cell Physiol"},{"key":"2022080412420706300_ref51","first-page":"2102","article-title":"Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis","volume":"32","author":"Mac\u00edas","year":"2005","journal-title":"J Rheumatol"},{"key":"2022080412420706300_ref52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cca.2020.03.024","article-title":"COX-2 in liver fibrosis","volume":"506","author":"Yang","year":"2020","journal-title":"Clin Chim Acta"},{"key":"2022080412420706300_ref53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13543776.2019.1623880","article-title":"Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)","volume":"29","author":"Mahboubi Rabbani","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"2022080412420706300_ref54","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood-2010-02-269605","article-title":"In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells","volume":"116","author":"Courties","year":"2010","journal-title":"Blood"},{"key":"2022080412420706300_ref55","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00277-019-03713-y","article-title":"Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo","volume":"98","author":"Jyotsana","year":"2019","journal-title":"Ann Hematol"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bmb\/article-pdf\/142\/1\/34\/45242097\/ldac012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bmb\/article-pdf\/142\/1\/34\/45242097\/ldac012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T08:42:48Z","timestamp":1659602568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article\/142\/1\/34\/6576180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,29]]},"published-print":{"date-parts":[[2022,7,9]]}},"URL":"https:\/\/doi.org\/10.1093\/bmb\/ldac012","relation":{},"ISSN":["0007-1420","1471-8391"],"issn-type":[{"value":"0007-1420","type":"print"},{"value":"1471-8391","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,3]]}}}